Top Read Articles

    Published in last 1 year |  In last 2 years |  In last 3 years |  All
    Please wait a minute...
    For Selected: Toggle Thumbnails
    Impact of miR-4674 expression changes on the biological characteristics of BGC-823 gastric cancer cell line
    YUAN Xiaobing, ZHU Jianwei
    Journal of Surgery Concepts & Practice    2025, 30 (04): 295-301.   DOI: 10.16139/j.1007-9610.2025.04.02
    Abstract585)   HTML37)    PDF(pc) (3825KB)(276)       Save

    Objective To explore the impact of miR-4674 expression changes on the biological characteristics of BGC-823 gastric cancer cell line based on bioinformatics research. Methods Through bioinformatics screening, miR-4674 was prioritized as a gastric cancer-associated miRNA. We constructed miR-4674 mimic, inhibitor, and corresponding negative control (NC) transfected into the BGC-823 cell line. Reverse transcription-polymerase chain reaction (RT-PCR) method was used to detect the expression changes of miR-4674 in BGC-823 cells. Functional assays included: MTT assay for cell proliferation ability; Transwell assay for migration capacity; TUNEL staining for cell apoptosis detection.Results Compared with the control group and cells transfected with NC, the level of miR-4674 was significantly increased in cells transfected with miR-4674 mimic, and the proliferation and migration abilities of the cells were significantly improved (P< 0.05). In cells transfected with miR-4674 inhibitor, the level of miR-4674 was significantly decreased, and the proliferation and migration abilities of the cells were significantly reduced (P<0.05). The result of TUNEL showed no significant differences in apoptotic rates were observed across all groups. Conclusions In the BGC-823 gastric cancer cell line, inhibition of miR-4674 expression can reduce its malignancy, while overexpression of miR-4674 can enhance its malignancy, suggesting its potential as a therapeutic target for gastric cancer intervention, providing a new strategy for the treatment of gastric cancer.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Expression and clinical significance of KIF15, EGFR, and HER2 in gallbladder cancer
    WANG Jun, WANG Lubing, HU Gangfeng, ZHANG Bo, HUANG Xia, HUANG Lei
    Journal of Surgery Concepts & Practice    2025, 30 (05): 409-416.   DOI: 10.16139/j.1007-9610.2025.05.06
    Abstract553)   HTML37)    PDF(pc) (5348KB)(437)       Save

    Objective To investigate the expression of kinesin family member 15(KIF15), epidermal growth factor receptor(EGFR), and human epidermal growth factor receptor 2(HER2) in gallbladder cancer(GBC) and their clinical and pathological significance. Methods Immunohistochemical staining was employed to detect the expression of KIF15, EGFR, and HER2 proteins in GBC tissue microarrays. The correlation between protein expression levels and various clinical and pathological characteristics of GBC patients was analyzed. Results The positive expression rates of KIF15, EGFR, and HER2 proteins in GBC tissues were 71.6%, 62.2%, and 51.4% respectively, compared to 16.7%, 0, and 0 in para-carcinoma tissues (all P=0.000). KIF15 expression was correlated with cancer differentiation grade (P=0.006), while EGFR expression was associated with lymph node metastasis(P=0.026) and the number of metastatic lymph nodes(P=0.012). HER2 expression was correlated with cancer differentiation grade(P=0.018), tumor size(P=0.005), and T stage(P=0.032). GBC patients with co-positive expression of KIF15 and HER2 had significantly lower overall survival compared to those with negative expression. Positive HER2 expression, lymph node metastasis, and the number of metastatic lymph nodes were identified as independent risk factors for overall survival in GBC patients. Conclusions Positive expression of KIF15, EGFR, and HER2 in GBC tissues are correlated with various clinical indicators and poorer prognosis. These proteins may serve as potential factors for predicting prognosis and evaluating therapeutic efficacy in GBC.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Asian consensus on normothermic intraperitoneal and systemic treatment for gastric cancer with peritoneal metastasis
    ZHU Zhenggang, Joji Kitayama, Hyung-Ho Kim, Jimmy Bok-Yan So, CAO Hui, CHEN Lin, CHENG Xiangdong, HU Jiankun, Motohiro Imano, Hironori Ishigami, Ye Seob Jee, Jong-Han Kim, Yasuhiro Kodera, LIANG Han, LIU Xiaowen, LU Sheng, MOU Yiping, NIE Mingming, Won Jun Seo, WANG Yanong, WU Dan, XU Zekuan, Hironori Yamaguchi, YAN Chao, YANG Zhongyin, YIN Kai, Yutaka Yonemura, Wei-Peng Yong, YU Jiren, ZHANG Jun, Asian Gastric Cancer NIPS Treatment Collaborative Group, Shanghai Anticancer Association, Committee of Peritoneal Tumor
    Journal of Surgery Concepts & Practice    2025, 30 (04): 277-294.   DOI: 10.16139/j.1007-9610.2025.04.01
    Abstract514)   HTML57)    PDF(pc) (1637KB)(782)       Save

    Gastric cancer with peritoneal metastasis (GCPM) is a common and lethal manifestation of advanced gastric cancer, with a median survival of only 5-11 months. This consensus was developed by 30 experts from Asia (China, Japan, Korea, and Singapore) using the Delphi method and the GRADE evidence grading system. A total of 29 statements were formulated, covering the diagnosis and assessment of GCPM, indications for laparoscopic exploration and NIPS (normothermic intraperitoneal and systemic treatment), treatment regimens, prevention and management of complications, criteria for conversion surgery, and postoperative intraperitoneal therapy. The consensus aims to standardize clinical practice and improve the prognosis of patients with GCPM.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Progression in circulating tumor DNA detection for minimal residual disease in patients with colorectal cancer liver metastasis
    LI Yaqi, MO Shaobo, PENG Junjie
    Journal of Surgery Concepts & Practice    2025, 30 (04): 351-357.   DOI: 10.16139/j.1007-9610.2025.04.10
    Abstract380)   HTML29)    PDF(pc) (982KB)(451)       Save

    As a non-invasive biomarker, circulating tumor DNA (ctDNA) can sensitively identify minimal residual disease (MRD), offering a novel approach for prognosis prediction and efficacy evaluation in patients with colorectal cancer liver metastasis (CRLM), thereby aiding in the formulation of personalized treatment strategies. This article summarized the progress in the application of ctDNA detection for MRD in CRLM and provided insights into its future directions.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Evolution and hot topics of laparoscopic sphincter-preserving surgery for low rectal cancer
    ZHI Yihao, ZHAO Xuan, ZHENG Minhua
    Journal of Surgery Concepts & Practice    2025, 30 (04): 358-363.   DOI: 10.16139/j.1007-9610.2025.04.11
    Abstract348)   HTML28)    PDF(pc) (872KB)(335)       Save

    Rectal cancer is a prevalent malignant tumor both in China and worldwide. Despite the availability of numerous sphincter-preserving procedures for low rectal cancer, each with specific indications, advantages, and limitations, no single procedure achieves optimal outcomes in all key domains: anal function preservation, surgical complication reduction, local recurrence rate minimization, and patient quality of life improvement. This article reviewed the evolutionary trajectory of laparoscopic sphincter-preserving surgery for low rectal cancer, while addressing current surgical challenges including prevention and management of anastomotic leakage, strategies for ensuring adequate distal resection margins, and functional outcomes prognosis. Corresponding countermeasures for these critical issues were systematically discussed.

    Reference | Related Articles | Metrics | Comments0
    Application experience of the cross-shaped coordinate line localization method in laparoscopic cholecystectomy
    LIANG Yong, SUN Jing, WU Weize
    Journal of Surgery Concepts & Practice    2025, 30 (05): 417-422.   DOI: 10.16139/j.1007-9610.2025.05.07
    Abstract334)   HTML30)    PDF(pc) (5751KB)(328)       Save

    Objective To explore the application of the “cross-shaped coordinate line localization method” in laparoscopic cholecystectomy (LC) to realize critical view of safety (CVS) as well as summarize its safety and practicality. Methods Eighty-four patients who were treated with the “cross-shaped coordinate line localization method” at the Department of General Surgery of Wuxi Branch of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine from February 2020 to February 2023 were selected as the observation group, and 84 patients who were randomly selected to receive the traditional LC treatment during the same period were selected as the control group. In the observation group, the “cross-shaped coordinate line localization method” was used as the boundary mark to reach CVS, and complete cholecystectomy. In the control group, the traditional blunt and sharp operation methods were used to free gallbladder triangle, and dissect out the cystic ducts and cystic arteries one by one and ligate them off. The intraoperative, postoperative and related complications of the two groups were compared and analyzed. Results All 168 patients successfully completed LC without serious surgical complications or conversion to open cases. The observation group took longer operation time to than the control group [(89.5±12.3) min vs. (67.7±8.9) min, P<0.001), and intraoperative blood loss was less than the control group [(7.0±3.9) mL vs. (15.2±4.6) mL, P<0.001). The rate of biliary and vascular anomalies in the observation group was higher than that in the control group (9.5% vs. 1.2%, P=0.040). The observation group had higher mobility on the first postoperative day than the control group, and time to first postoperative feeding and time to first postoperative flatus were earlier than those of the control group (P<0.05). The overall incidence rate of related complications in the observation group was lower than that in the control group (2.4% vs. 10.7%, P=0.029). There was no statistically significant difference between the two groups in terms of drain placement and length of hospital stay (P>0.05). Conclusions The “cross-shaped coordinate line localization method”, with its constant anatomical position as the basic symbol, can help surgeons quickly lock the safe operation area and realize CVS of the gallbladder triangle to avoid bile duct injury and reduce the incidence of related complications.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Efficacy variations of adjuvant chemotherapy across disease stages in duodenal adenocarcinoma: a multivariate survival analysis based on the SEER database
    WANG Yu, HU Kaixin, ZHAO Fengqing, LI Huangbao
    Journal of Surgery Concepts & Practice    2025, 30 (05): 428-437.   DOI: 10.16139/j.1007-9610.2025.05.09
    Abstract307)   HTML32)    PDF(pc) (951KB)(432)       Save

    Objective To investigate the efficacy of adjuvant chemotherapy for patients with duodenal adenocarcinoma (DAC) at different stages. Methods A retrospective analysis was performed on patients diagnosed with DAC between January 2000 and December 2021 using data from the SEER database. Kaplan-Meier curves were utilized to evaluate the impact of adjuvant chemotherapy on survival outcomes in DAC patients with different stages. Univariate and multivariate COX regression analyses were performed to determine whether adjuvant chemotherapy served as an independent prognostic factor for cancer-specific survival (CSS) and overall survival (OS). Results A total of 1 195 patients meeting the inclusion criteria were included in the study. Of these, 620 patients (51.9%) received adjuvant chemotherapy after surgery were defined as the adjuvant chemotherapy group, whereas 575 patients (48.1%) underwent surgery alone were defined as the other group. After propensity score matching, 634 patients were retained for subsequent analysis. Subgroup analysis demonstrated that there were statistically significant differences in CSS and OS between the adjuvant chemotherapy group and other group for stage ⅢA and ⅢB patients (P < 0.05), while no statistically significant differences in CSS and OS between the adjuvant chemotherapy group and other group for stageⅠ, stageⅡA, stage ⅡB patients (P > 0.05). Multivariate analysis identified adjuvant chemotherapy as an independent protective factor for both CSS and OS in DAC patients. Additionally, age, year of diagnosis, tumor grade, number of regional lymph nodes examined (RNE), and TNM stage were identified as independent protective or risk factors for CSS and OS (all P < 0.05). Conclusions Based on substage stratification, the survival benefits of adjuvant chemotherapy for DAC patients are as follows: patients with stage ⅢA and ⅢB benefit in both CSS and OS, while patients with stage Ⅰ, Ⅱ A, and ⅡB do not benefit in either CSS or OS.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Interpretation of the 2025 American Society for Gastrointestinal Endoscopy guideline on diagnosis and management of GERD
    SANG Huaiming, WU Gaojue, TANG Yurong
    Journal of Surgery Concepts & Practice    2025, 30 (05): 385-391.   DOI: 10.16139/j.1007-9610.2025.05.03
    Abstract297)   HTML47)    PDF(pc) (1002KB)(1064)       Save

    Released in February 2025, American Society for Gastrointestinal Endoscopy(ASGE) guideline on the diagnosis and management of gastroesophageal reflux disease(GERD), is based on a large body of evidence-based medical evidence over the past decade. It has systematically updated the indications for endoscopic examination, standards for high-quality endoscopic examination, and multidimensional management strategies, while focusing on elucidating the new role of endoscopic intervention in the diagnosis and treatment of GERD. The guideline aimed to provide clinicians with an authoritative guiding tool that integrates both scientific and practical value.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Comprehensive diagnosis and treatment strategy for functional pancreas neuroendocrine neoplasm: a report of 3 cases
    JI Bei, SHANG Zhengye, TUO Biguang, LIU Xuemei
    Journal of Surgery Concepts & Practice    2025, 30 (05): 438-443.   DOI: 10.16139/j.1007-9610.2025.05.10
    Abstract297)   HTML23)    PDF(pc) (4723KB)(381)       Save

    Functional neuroendocrine neoplasm, which secrete hormones and lead to diverse clinical symptoms, pose significant challenges in diagnosis and treatment. Early identification and standardized management are crucial for improving patient prognosis. This article summarized three clinically relatively common cases of Functional pancreatic neuroendocrine neoplasm (F-pNENs), focusing on analyzing their diagnostic key points and standardized therapeutic pathways. It aimed to provide reference for early clinical identification of rare tumors and improvement of standardized multidisciplinary diagnosis and treatment as well as personalized treatment strategies.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Current status and reflections on immunotherapy and targeted therapy for unresectable biliary tract cancer
    YU Liqin, YAN Xiaoyu, WANG Puxiongzhi, WANG Wei, WANG Jian
    Journal of Surgery Concepts & Practice    2025, 30 (06): 544-550.   DOI: 10.16139/j.1007-9610.2025.06.14
    Abstract277)   HTML27)    PDF(pc) (939KB)(316)       Save

    Biliary tract cancer (BTC) represents a group of highly malignant solid tumors with a five-year survival rate of only 10%. For patients with unresectable BTC, gemcitabine combined with cisplatin has been the conventional first-line treatment regimen. With the remarkable efficacy of immunotherapy and targeted therapy observed in other solid tumors, numerous studies have investigated their potential in unresectable BTC. This article provides an overview of the current status of targeted and immunotherapeutic approaches for unresectable BTC, with a focus on research advancements in immune checkpoint inhibitor (ICI) and targeted agents against fibroblast growth factor receptor(FGFR), isocitrate dehydrogenase(IDH), and human epidermal growth factor receptor 2(HER2), as well as future trends in immunotherapy and targeted therapy, aiming to contribute to the development of more effective treatment strategies.

    Reference | Related Articles | Metrics | Comments0
    Characteristics of cyst fluid can predict the benign or malignant nature of intraductal papillary mucinous neoplasms
    WANG Jingyuan, FAN Jiayu, ZHANG Pingping, MA Hongyun, CHEN Ying, LI Gang, JIN Zhendong, JIN Gang, WANG Kaixuan
    Journal of Surgery Concepts & Practice    2025, 30 (06): 509-516.   DOI: 10.16139/j.1007-9610.2025.06.09
    Abstract269)   HTML30)    PDF(pc) (1972KB)(263)       Save

    Objective To investigate the predictive ability of cyst fluid characteristics for malignant intraductal papillary mucinous neoplasms (IPMNs). Methods We prospectively collected fresh cyst fluid from patients undergoing pancreatic resection at the Department of Hepatobiliary Pancreatic Spleen Surgery, Changhai Hospital, Shanghai, from September 2023 to December 2024, who were ultimately pathologically confirmed with IPMN. We assessed the characteristics of cyst fluid, including viscosity, clarity, and color, and explored its predictive performance for benign or malignant. Results A total of 40 patients with IPMN were included. The sensitivity of the string sign (+) for diagnosing high-grade dysplasia/ invasive carcinoma (HGD/IC) was 90.9%, specificity was 92.9%, and accuracy was 76.0%. The cyst fluid of intestinal-type IPMN often exhibited a gelatinous consistency, and there was no significant difference in the distribution of gelatinous consistency between the HGD/IC group and the low-grade dysplasia (LGD) group. There were no significant differences in CEA, glucose, and amylase levels in the cyst fluid between the HGD/IC group and the LGD group. Conclusions The characteristics of pancreatic cyst fluid, especially viscosity, can effectively predict the benign or malignant nature of IPMN.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Current status and prospects of minimally invasive surgery for breast cancer in China
    DUAN Shiyu, JIN Yiting
    Journal of Surgery Concepts & Practice    2025, 30 (06): 537-543.   DOI: 10.16139/j.1007-9610.2025.06.13
    Abstract264)   HTML25)    PDF(pc) (928KB)(247)       Save

    This article provided a systematic review of the current application and development prospect of minimally invasive surgery for breast cancer in China. Although application of endoscopic and robotic surgical procedures remain limited in breast surgery, they have shown advantages in cosmetic outcomes and postoperative recovery across various procedures, including axillary lymph node dissection, breast-conserving surgery, mastectomy, and breast reconstruction. Nonetheless, further high-quality clinical evidence is needed to confirm their long-term oncological safety. Despite current challenges of prolonged operation time and high medical cost, minimally invasive techniques are poised to become an integral component of breast cancer surgical care with continuous refinements of technology and accumulating clinical evidence.

    Reference | Related Articles | Metrics | Comments0
    Application and advancements of endoscopy in the management of pancreatic intraductal papillary mucinous neoplasm
    XU Wanqian, ZHOU Chunhua, ZOU Duowu
    Journal of Surgery Concepts & Practice    2025, 30 (05): 369-377.   DOI: 10.16139/j.1007-9610.2025.05.01
    Abstract249)   HTML20)    PDF(pc) (915KB)(377)       Save

    Pancreatic intraductal papillary mucinous neoplasm (IPMN) is a pancreatic cystic lesion with malignant potential, the management of which relies on accurate diagnosis, risk stratification, and surveillance. Endoscopic techniques, particularly endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP), play crucial roles in the diagnosis, risk assessment, and therapeutic decision-making for IPMN. However, their application still faces challenges including technical limitations, operator dependence, cost-effectiveness considerations, and controversies regarding long-term surveillance strategies.This article comprehensively reviewed the current applications and recent advancements in gastrointestinal endoscopy for managing IPMN, and discussed future directions for refining personalized, precision-based treatment approaches.

    Reference | Related Articles | Metrics | Comments0
    Construction of prediction model for acute hypertension following laparoscopic sleeve gastrectomy in obese patients
    WANG Yue, GUO Junwei, YUAN Hang, DU Lei, JIA Xuyang, BU Le, Lu Liesheng
    Journal of Surgery Concepts & Practice    2025, 30 (05): 400-408.   DOI: 10.16139/j.1007-9610.2025.05.05
    Abstract245)   HTML7)    PDF(pc) (1781KB)(213)       Save

    Objective To investigate the high-risk factors associated with acute postoperative hypertension (APH) following laparoscopic sleeve gastrectomy(LSG) in obese patients and to establish a predictive model. Methods A retrospective analysis was conducted on clinical data and laboratory parameters of obese patients who underwent LSG at Department of Metabolic Surgery in our hospital from August 2021 to December 2023. Logistic-LASSO regression analysis was used to identify independent risk factors for APH. A nomogram predictive model was developed based on these factors. The predictive performance and clinical utility of the model were assessed using the receiver operating characteristic (ROC) curve, Bootstrap resampling, calibration curve, Hosmer-Lemeshow (H-L) test, decision curve analysis (DCA), and clinical impact curve (CIC). Results The incidence of APH was 55.90%. Body mass index (BMI), platelet count, globulin, uric acid, sodium, fibrinogen, fasting blood glucose, and preoperative diastolic pressure had potential predictive value. Among them, BMI (OR=1.066, 95% CI: 1.003-1.137, P=0.046), platelet count (OR=0.994, 95% CI: 0.998-0.999, P=0.027), fibrinogen (OR=1.943, 95% CI: 1.128-3.479, P=0.02), and preoperative diastolic blood pressure (OR=0.953, 95% CI: 0.918-0.985, P = 0.006) were identified as independent high-risk factors. The area under the curve (AUC) of the nomogram was 0.783 (95% CI: 0.711-0.855), with a sensitivity of 0.817 and a specificity of 0.689. The AUC based on Bootstrap resampling was 0.776 (95% CI: 0.702-0.849). The H-L test yielded P>0.05, and the calibration curve showed good model fit. Both DCA and CIC demonstrated favorable screening efficiency. Conclusions BMI, platelet count, fibrinogen, and preoperative diastolic blood pressure are independent high-risk factors for APH following LSG. The developed nomogram model exhibits good predictive performance and clinical applicability, providing a valuable tool for early screening and prevention of APH in LSG patients.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Research progress on the mechanism of regulated cell death in thyroid carcinoma
    NIU Lingshan, ZHAO Yue, SHI Xu, YANG Zheyu, PAN Ruijun, CAI Wei
    Journal of Surgery Concepts & Practice    2025, 30 (06): 529-536.   DOI: 10.16139/j.1007-9610.2025.06.12
    Abstract238)   HTML6)    PDF(pc) (1254KB)(255)       Save

    Thyroid carcinoma is one of the malignant tumors with rapidly increasing incidence rates. Some refractory patients face challenges from drug toxicity and resistance, urgently requiring the discovery of new therapeutic pathways to improve prognosis. Regulatory cell death(RCD)is a highly regulated orderly death mode, including apoptosis, necroptosis, pyroptosis, ferroptosis, and cuproptosis. Recent studies have found that RCD is closely associated with tumor progression, invasion, and resistance. This article systematically reviewed various death modes in thyroid cancer, including the core signaling nodes of each death pathway, and explored their specific functions in tumor progression. It also summarized potential therapeutic strategies targeting these death pathways. However, the complexity of RCD mechanisms and the sensitivity of treatments remain controversial. Future efforts should focus on screening broad-spectrum targets and developing synergistic therapies to ultimately achieve precise treatment based on cell death, thereby improving the prognosis of refractory thyroid cancer.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Intrahepatic cholangiocarcinoma tumor size classification based on prognostic analysis: a retrospective multicenter study
    CHEN Jiaqian, LIU Hongzhi, MENG Lingtian, ZHOU Weiping, CHENG Zhangjun, LOU Jianying, ZHENG Shuguo, BI Xinyu, WANG Jianming, GUO Wei, LI Fuyu, WANG Jian, ZHENG Yamin, LI Jingdong, CHENG Shi, HUANG Yao, ZENG Yongyi
    Journal of Surgery Concepts & Practice    2025, 30 (04): 332-338.   DOI: 10.16139/j.1007-9610.2025.04.07
    Abstract224)   HTML6)    PDF(pc) (1118KB)(232)       Save

    Objective To retrospectively analyze multicenter data from domestic sources, aiming to explore the link between intrahepatic cholangiocarcinoma (ICC) tumor size and prognosis, establishing a classification system based on tumor size. Methods Between December 2011 and September 2018, 280 ICC patients from 13 hospitals were included. The tumor size prognosis cutoff was identified by the minimum P-value method, and the classification's overall survival related effectiveness was assessed by Kaplan-Meier analysis. Results All 280 patients were divided into the group of tumor maximum diameter ≤4 cm and >4 cm. Tumor size was confirmed as an independent prognosis factor by multivariate COX regression analysis (HR=2.110, 95% CI: 1.358-3.280). Conclusions The tumor size dichotomy classification system based on the Chinese patient group can expediently predict ICC prognosis and offers an important basis for selecting post-operative individualized adjuvant therapy and follow up plans.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Construction and validation of a machine learning-based prediction model for very early recurrence after curative-intent resection for gallbladder cancer
    TANG Zhenqi, LI Qi, LIU Hengchao, ZHANG Dong, GENG Zhimin
    Journal of Surgery Concepts & Practice    2025, 30 (04): 316-324.   DOI: 10.16139/j.1007-9610.2025.04.05
    Abstract220)   HTML8)    PDF(pc) (1729KB)(364)       Save

    Objective To explore the risk factors for very early recurrence (VER) after curative-intent resection for gallbladder cancer (GBC) patients and construct prediction models for VER based on various machine learning (ML) algorithms. Methods A retrospective study was conducted on 329 GBC patients who underwent curative-intent surgery at our hospital between January 2016 and December 2020. Risk factors for VER were identified, and prediction models were constructed, validated and compared with multiple ML algorithms[logistic regression (LR), support vector machine (SVM), naive Bayes (NB), random forest (RF), light gradient boosting machine (LGB), and extreme gradient boosting (XGB)]based on independent associated factors for VER. Results Among the 329 patients who underwent curative-intent resection in patients with GBC, 162 (49.2%) patients experienced recurrence, including 69 (42.6%) with VER(<6 months) and 93 (57.4%) with non-VER(≥6 months). Survival analysis showed that patients with VER had significantly worse median overall survival compared to those with non-VER (6 months vs. not arrived,χ2=398.2, P<0.001). Univariate analysis showed that carcinoembryonic antigen (CEA), carbohydrate antigen (CA)19-9, CA-125, tumor differentiation, pathological type, liver involvement, vascular invasion, perineural invasion, TNM stage, T stage and N stage were risk factors of VER (P<0.05), whereas adjuvant chemotherapy was protective factor (P<0.05). Multivariate analysis confirmed CA-125, tumor differentiation, pathological type, vascular invasion and N stage as independent risk factors (P<0.05), whereas adjuvant chemotherapy was independent protective factor (P<0.05). XGB model achieved the best performance with an area under curve (AUC) of 0.841 and an accuracy (ACC) of 83.0% in the validation set. Shapley additive explanations (SHAP) bar plots highlighted tumor differentiation, N stage, pathological type of tumor, and CA-125 the top four features contributing to the model, each positively influencing the predicted probability of VER. Conclusions CA-125, tumor differentiation, pathological type, vascular invasion, N stage and adjuvant chemotherapy are independent factors associated with VER of GBC following curative-intent resection. ML-based prediction models incorporating these factors have the potential to some extent to effectively identify high-risk patients, providing a valuable reference for VER surveillance in GBC.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Prevention of seroma after laparoscopic totally extraperitoneal hernia repair: a retrospective analysis
    LIU Dejun, HU Xingchen
    Journal of Surgery Concepts & Practice    2025, 30 (05): 423-427.   DOI: 10.16139/j.1007-9610.2025.05.08
    Abstract217)   HTML5)    PDF(pc) (2357KB)(253)       Save

    Objective To evaluate the efficacy of intraoperative negative pressure drainage in preventing seroma after laparoscopic totally extraperitoneal (TEP) hernia repair. Methods A total of 200 patients undergoing TEP repair in our hospital from January 2022 to December 2022 were divided into two groups (n=100 each). The study group received intraoperative negative pressure drainage, while the control group did not. Therapeutic outcomes and postoperative complications were compared between the two groups. Results There were no significant differences between the two groups in operative time, pain scores, incidence of wound infection, or recurrence rates (P > 0.05). However, the study group showed a significantly lower incidence of postoperative seroma compared to the control group (P < 0.05). For direct hernias, the operative time in the study group was significantly shorter than that in the control group (P < 0.05). No mesh infections were observed in either group. Conclusions Prophylactic negative pressure drainage significantly reduces seroma formation without increasing other postoperative complications and is easy to be performed. The application of negative pressure drainage is recommended in cases of scrotal and direct hernias.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Advantages and challenges of different endoscopic bariatric technologies in the treatment of obesity — interpretation of Expert consensus on digestive endoscopic treatment for obesity in China
    SUN Haowen, YIN Yuzhe, WANG Yiting, XUE Yuzheng
    Journal of Surgery Concepts & Practice    2025, 30 (05): 392-399.   DOI: 10.16139/j.1007-9610.2025.05.04
    Abstract211)   HTML8)    PDF(pc) (845KB)(208)       Save

    Obesity has emerged as a major global public health challenge, accompanied by a significant rise in obesity-related comorbidities. Although conventional bariatric surgery achieves reliable outcomes, its invasiveness, potential risks, and irreversible anatomical alterations have limited widespread application. With the rapid advancement of digestive endoscopy, endoscopic bariatric therapies are increasingly recognized as minimally invasive alternatives that combine safety and efficacy. This review summarized the current progress and clinical applications of various endoscopic bariatric techniques, including intragastric balloons, endoscopic sleeve gastroplasty, and primary obesity surgery endoluminal procedures that reduced gastric volume via space-occupying, or suture and anastomosis technology achieved by oral devices. In addition, aspiration therapy, which removes gastric contents, and innovative methods such as duodenal-jejunal bypass liners and duodenal mucosal resurfacing that mimic surgical bypass or induce mucosal remodeling were discussed. Endoscopic bariatric technologies showed promising prospects and were expected to become an important component of comprehensive obesity management.

    Reference | Related Articles | Metrics | Comments0
    Advances in endoscopic ultrasound-guided celiac plexus neurolysis and its derivative techniques
    AO Xinyi, LI Li, LI Zhi, WANG Kaixuan
    Journal of Surgery Concepts & Practice    2025, 30 (05): 378-384.   DOI: 10.16139/j.1007-9610.2025.05.02
    Abstract205)   HTML7)    PDF(pc) (851KB)(200)       Save

    This review systematically summarizes the clinical applications and recent advances of endoscopic ultrasound-guided celiac plexus neurolysis (EUS-CPN) and its derived techniques. It addressed the indications, contraindications, technical challenges, and procedural principles, with a detailed overview of unilateral and bilateral injection, EUS-guided celiac ganglia neurolysis (EUS-CGN), EUS-guided broad-plexus neurolysis (EUS-BPN), as well as radiofrequency ablation and radioactive seed implantation. In addition, complications and their preventive strategies were discussed, and future directions were highlighted, aiming to provide technical references and decision-making guidance for clinical practice.

    Table and Figures | Reference | Related Articles | Metrics | Comments0